Medical abortion (Simple English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Medical abortion" in Simple English language version.

refsWebsite

Global rank Simple English rank

2^nd place

3^rd place

4^th place

6^th place

11^th place

9^th place

low place

447^th place

1,594^th place

low place

ansirh.org (Global: low place; Simple English: low place)

"Analysis of Medication Abortion Risk and the FDA report - "Mifepristone U.S. Post-Marketing Adverse Events Summary through 12/31/2018"" (PDF). Bixby Center for Global Reproductive Health. 2019-04-01. The mortality rate for women known to have had a live-born infant is 8.8 per 100,000 live births, which is about 14 times higher than the mortality rate associated with medication abortion. Other medications that are commonly prescribed or administered in outpatient settings also have risks, including a small risk of death. Penicillin causes a fatal anaphylactic reaction at a rate of 2 deaths per 100,000 patients administered the drug. Phosphodiesterase type-5 inhibitors, which are used for erectile dysfunction and include Viagra, have a fatality rate of 4 deaths per 100,000 users. These risks are several times higher than the risk of death with medication abortion.

Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A (2004). Kulier, Regina (ed.). "Medical methods for first trimester abortion". Cochrane Database Syst Rev (2): CD002855. doi:10.1002/14651858.CD002855.pub3. PMID 15106180.{{cite journal}}: CS1 maint: article number as page number (link) CS1 maint: multiple names: authors list (link)
Vlad S, Boucoiran I, St-Pierre ÉR, Ferreira E (February 2022). "Mifepristone-Misoprostol Use for Second and Third Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre". J Obstet Gynaecol Can. 44 (6): 683–689. doi:10.1016/j.jogc.2021.12.010. PMID 35114381. S2CID 246505706.

Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A (2004). Kulier, Regina (ed.). "Medical methods for first trimester abortion". Cochrane Database Syst Rev (2): CD002855. doi:10.1002/14651858.CD002855.pub3. PMID 15106180.{{cite journal}}: CS1 maint: article number as page number (link) CS1 maint: multiple names: authors list (link)
Vlad S, Boucoiran I, St-Pierre ÉR, Ferreira E (February 2022). "Mifepristone-Misoprostol Use for Second and Third Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre". J Obstet Gynaecol Can. 44 (6): 683–689. doi:10.1016/j.jogc.2021.12.010. PMID 35114381. S2CID 246505706.

Vlad S, Boucoiran I, St-Pierre ÉR, Ferreira E (February 2022). "Mifepristone-Misoprostol Use for Second and Third Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre". J Obstet Gynaecol Can. 44 (6): 683–689. doi:10.1016/j.jogc.2021.12.010. PMID 35114381. S2CID 246505706.